The Spanish pharmaceutical company Grifols is producing albumin for sale internationally, thanks to a new contract with Canadian Blood Services that allows the company to use plasma-donation byproducts for its own for-profit medicines.
Breakdown
- Canadian Blood Services is selling plasma byproducts to Spanish company Grifols. 9s
- This move contradicts previous assurances that Canadian blood would be used only for Canadians. 13s
- Grifols CEO confirmed Canadian plasma is now used to make albumen for sale abroad. 26s
- Advocates and donors express concern over the commercialization of blood donations. 1m 51s
- Canadian Blood Services says the deal ensures sufficient albumen supply and offsets drug production costs. 2m 27s